Vanguard Community Health Centre, Western Cape Department of Health, Cape Town.
Afr J Prim Health Care Fam Med. 2021 Sep 30;13(1):e1-e3. doi: 10.4102/phcfm.v13i1.3088.
A group of Vanguard Community Health Centre doctors embarked on a Health System's Improvement (HSI) project with the aim of reducing harm to renal function in patients who were either commenced on or switched to a dolutegravir (DTG)-based antiretroviral therapy (ART) regimen since 2019, when the usual monitoring and evaluation of ART-regimen switches were disrupted by the coronavirus disease 2019 (COVID-19) pandemic. This intended harm-reduction exercise, involving a reflective process that was facilitated by the family physician, led to the development of a Vanguard Renal Protection Surveillance tool, which is now used at Vanguard to detect and prevent renal decline.
一群先锋社区健康中心的医生开展了一项卫生系统改进（HSI）项目，目的是减少自 2019 年冠状病毒病 2019（COVID-19）大流行以来开始或改用多替拉韦（DTG）为基础的抗逆转录病毒治疗（ART）方案的患者的肾功能损害。这项旨在减少伤害的工作，涉及到家庭医生协助的反思过程，导致了先锋肾脏保护监测工具的开发，现在在先锋社区健康中心用于检测和预防肾功能下降。
